Showing 1 - 4 results of 4 for search 'Anne-Claire Dupont', query time: 0.03s Refine Results
  1. 1
    Case Report: Contribution of [18F]FET PET in differential diagnosis between radionecrosis and progression in metastasis—reproducibility and superiority of dynamic acquisitions

    Case Report: Contribution of [18F]FET PET in differential diagnosis between radionecrosis and progression in metastasis—reproducibility and superiority of dynamic acquisitions by Aurélien Callaud, Anne-Claire Dupont, Anne-Claire Dupont, Marie-Agnes By, Ilyess Zemmoura, Ilyess Zemmoura, Maria-Joao Santiago-Ribeiro, Maria-Joao Santiago-Ribeiro

    Published 2024-02-01
    Get full text
    Article
  2. 2
    Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks

    Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks by Anne-Claire Dupont, Nicolas Arlicot, Johnny Vercouillie, Sophie Serrière, Serge Maia, Frédérique Bonnet-Brilhault, Maria-Joao Santiago-Ribeiro

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Fully automated radiosynthesis of [18F]LBT999 on TRACERlab FXFN and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain

    Fully automated radiosynthesis of [18F]LBT999 on TRACERlab FXFN and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain by Christine Vala, Céline Mothes, Gabrielle Chicheri, Pauline Magadur, Gilles Viot, Jean-Bernard Deloye, Serge Maia, Yann Bouvet, Anne-Claire Dupont, Nicolas Arlicot, Denis Guilloteau, Patrick Emond, Johnny Vercouillie

    Published 2020-11-01
    Get full text
    Article
  4. 4
    Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.

    Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II... by Amélie Anota, Guillaume Mouillet, Isabelle Trouilloud, Anne-Claire Dupont-Gossart, Pascal Artru, Thierry Lecomte, Aziz Zaanan, Mélanie Gauthier, Francine Fein, Olivier Dubreuil, Sophie Paget-Bailly, Julien Taieb, Franck Bonnetain

    Published 2015-01-01
    Get full text
    Article

Search Tools: